Cardiff Lexington Corp
Cardiff Lexington Corporation, through its subsidiaries, provides orthopedics, spine care, and pain management services in the United States. The company operates in two segments, Healthcare and Real Estate. The Healthcare provides diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. The company a… Read more
Cardiff Lexington Corp (CDIX) - Net Assets
Latest net assets as of September 2025: $5.01 Million USD
Based on the latest financial reports, Cardiff Lexington Corp (CDIX) has net assets worth $5.01 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($27.61 Million) and total liabilities ($22.60 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $5.01 Million |
| % of Total Assets | 18.16% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 83.82 |
Cardiff Lexington Corp - Net Assets Trend (2005–2024)
This chart illustrates how Cardiff Lexington Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cardiff Lexington Corp (2005–2024)
The table below shows the annual net assets of Cardiff Lexington Corp from 2005 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $7.60 Million | +14.80% |
| 2023-12-31 | $6.62 Million | +550.50% |
| 2022-12-31 | $-1.47 Million | -152.84% |
| 2021-12-31 | $2.78 Million | +131.35% |
| 2020-12-31 | $-8.87 Million | -31.90% |
| 2019-12-31 | $-6.73 Million | -38.80% |
| 2018-12-31 | $-4.85 Million | -34.94% |
| 2017-12-31 | $-3.59 Million | -124.55% |
| 2016-12-31 | $-1.60 Million | -161.97% |
| 2015-12-31 | $-610.49K | +66.25% |
| 2014-12-31 | $-1.81 Million | +62.38% |
| 2013-12-31 | $-4.81 Million | +41.24% |
| 2011-12-31 | $-8.18 Million | -147.72% |
| 2010-12-31 | $-3.30 Million | -56.47% |
| 2008-12-31 | $-2.11 Million | +0.01% |
| 2007-12-31 | $-2.11 Million | -2.05% |
| 2006-12-31 | $-2.07 Million | +0.96% |
| 2005-12-31 | $-2.09 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cardiff Lexington Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7236648700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $15.30K | 0.20% |
| Other Components | $80.54 Million | 1059.49% |
| Total Equity | $7.60 Million | 100.00% |
Cardiff Lexington Corp Competitors by Market Cap
The table below lists competitors of Cardiff Lexington Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Seafresh Industry Public Company Limited
BK:CFRESH
|
$8.09 Million |
|
Everest Metals Corporation Ltd
AU:EMC
|
$8.09 Million |
|
ABCO Electronics Co. Ltd
KQ:036010
|
$8.09 Million |
|
Elah Holdings Inc
PINK:ELLH
|
$8.09 Million |
|
D.T.C. Enterprise PCL
BK:DTCENT
|
$8.09 Million |
|
ZincX Resources Corp
PINK:ZNCXF
|
$8.09 Million |
|
JKG Land Bhd
KLSE:6769
|
$8.09 Million |
|
Alfa Energi Investama Tbk PT
JK:FIRE
|
$8.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cardiff Lexington Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 6,621,522 to 7,601,274, a change of 979,752 (14.8%).
- Net loss of 3,302,999 reduced equity.
- Dividend payments of 100,000 reduced retained earnings.
- Other comprehensive income increased equity by 9,365,982.
- Other factors decreased equity by 4,983,231.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.30 Million | -43.45% |
| Dividends Paid | $100.00K | -1.32% |
| Other Comprehensive Income | $9.37 Million | +123.22% |
| Other Changes | $-4.98 Million | -65.56% |
| Total Change | $- | 14.80% |
Book Value vs Market Value Analysis
This analysis compares Cardiff Lexington Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.56x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | $0.00 | $3.10 | x |
| 2004-12-31 | $0.00 | $3.10 | x |
| 2005-12-31 | $-0.04 | $3.10 | x |
| 2006-12-31 | $-0.28 | $3.10 | x |
| 2007-12-31 | $-0.01 | $3.10 | x |
| 2010-12-31 | $-0.19 | $3.10 | x |
| 2011-12-31 | $-0.45 | $3.10 | x |
| 2013-12-31 | $-4808577.00 | $3.10 | x |
| 2014-12-31 | $-0.01 | $3.10 | x |
| 2015-12-31 | $0.00 | $3.10 | x |
| 2016-12-31 | $-941.32 | $3.10 | x |
| 2017-12-31 | $-3591279.00 | $3.10 | x |
| 2018-12-31 | $-242311.30 | $3.10 | x |
| 2019-12-31 | $-0.09 | $3.10 | x |
| 2020-12-31 | $-385753.65 | $3.10 | x |
| 2021-12-31 | $0.02 | $3.10 | x |
| 2022-12-31 | $-757.63 | $3.10 | x |
| 2023-12-31 | $993.18 | $3.10 | x |
| 2024-12-31 | $1.99 | $3.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cardiff Lexington Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -43.45%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -39.94%
- • Asset Turnover: 0.35x
- • Equity Multiplier: 3.15x
- Recent ROE (-43.45%) is below the historical average (-0.62%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.15K |
| 2004 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.01K |
| 2005 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.46 Million |
| 2006 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.07 Million |
| 2007 | 0.00% | 0.00% | 0.00x | 0.00x | $-577.45K |
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-577.46K |
| 2010 | 0.00% | -620373.22% | 0.02x | 0.00x | $-804.92K |
| 2011 | 0.00% | -1081988.93% | 0.01x | 0.00x | $-2.02 Million |
| 2013 | 0.00% | 71066.15% | 0.20x | 0.00x | $1.08 Million |
| 2014 | 0.00% | -1233.49% | 128.39x | 0.00x | $-10.80 Million |
| 2015 | 0.00% | -283.85% | 1.15x | 0.00x | $-3.88 Million |
| 2016 | 0.00% | -196.00% | 0.47x | 0.00x | $-2.09 Million |
| 2017 | 0.00% | -224.63% | 1.24x | 0.00x | $-3.29 Million |
| 2018 | 0.00% | -281.35% | 0.67x | 0.00x | $-5.78 Million |
| 2019 | 0.00% | -193.67% | 0.75x | 0.00x | $-6.51 Million |
| 2020 | 0.00% | -82.16% | 0.70x | 0.00x | $-1.95 Million |
| 2021 | -14.73% | -4.09% | 0.90x | 4.01x | $-687.84K |
| 2022 | 0.00% | -50.78% | 0.80x | 0.00x | $-5.28 Million |
| 2023 | 45.74% | 25.55% | 0.57x | 3.13x | $2.37 Million |
| 2024 | -43.45% | -39.94% | 0.35x | 3.15x | $-4.06 Million |
Industry Comparison
This section compares Cardiff Lexington Corp's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $250,407,165
- Average return on equity (ROE) among peers: -38.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cardiff Lexington Corp (CDIX) | $5.01 Million | 0.00% | 4.51x | $8.09 Million |
| Addus HomeCare Corporation (ADUS) | $113.86 Million | 16.82% | 0.44x | $1.75 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $166.17 Million |
| Airsculpt Technologies Inc (AIRS) | $123.68 Million | 6.13% | 0.45x | $16.62 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $7.93 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $225.22 Million |
| Arem Pacific Corporation (ARPC) | $-45.09K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.08 Billion |